Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Biota Pharmaceuticals Inc    NABI   US6295191091

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Biota Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of products to prevent and treat serious and potentially life-threatening infectious diseases. The Company currently has two Phase 2 clinical-stage product candidates in development: laninamivir... 
More about the company
Financials ($)
Sales 2014 73,3 M
EBIT 2014 -7,17 M
Net income 2014 -
Debt 2014 -
Yield 2014 -
Sales 2015 29,0 M
EBIT 2015 -27,3 M
Net income 2015 -
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 1,60x
Capi. / Sales 2015 4,05x
Capitalization 117 M
More Financials
Latest news on BIOTA PHARMACEUTICALS INC
06/03 BIOTA PHARMACEUTICALS : Announces Restructuring Plan
06/02 BIOTA PHARMACEUTICALS : Costs Associated with Exit or Disposal Activities, Other..
06/02 Biota Announces Restructuring Plan
05/28 Biota to Present at the Jefferies 2014 Global Healthcare Conference
05/21 BIOTA PHARMACEUTICALS : Faruqi & Faruqi, LLP Encourages Investors Who Suffered S..
05/12 BIOTA PHARMACEUTICALS : 34% Drop in Biota Pharmaceutical, Inc.'s Stock Price: La..
05/09 BIOTA PHARMACEUTICALS : Faruqi & Faruqi, LLP : Encourages Investors Who Suffered..
05/08 BIOTA PHARMACEUTICALS : Provides Update on BARDA Contract for Laninamivir Octano..
05/07 BIOTA PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8-..
05/07 BIOTA PHARMACEUTICALS : Reports Third Quarter 2014 Financial Results and Recent ..
05/06 BIOTA PHARMACEUTICALS : Reports Third Quarter 2014 Financial Results and Recent ..
05/01 BIOTA PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8-..
More news
Comments 
Advertisement
Income Statement Evolution
Biota Pharmaceuticals Inc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF